The HIV prevention pill, PrEP, will be available on the Pharmaceutical Benefits Scheme from April 1, giving Australia its greatest opportunity yet to drive serious reductions in HIV transmission.

Dean Arcuri reports on what this means with Darryl O’Donnell, chief executive of the Australian Federation of AIDS Organisations. PrEP is 99 per cent effective at preventing HIV transmission among gay and bisexual men.

It will be available to people at high risk of HIV at a cost of $39.50 per month (General Patients), with users receiving a three month prescription and a sexual health check each time they visit their GP.

This aired on The Informer on 21st March 2018.